Unlock stock picks and a broker-level newsfeed that powers Wall Street.
3.5400
+0.2900
+(8.92%)
At close: 4:00:01 PM EDT
3.3700
-0.17
(-4.80%)
After hours: 6:10:44 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 9 | 8 |
| Avg. Estimate | -0.24 | -0.21 | -0.78 | -0.34 |
| Low Estimate | -0.26 | -0.25 | -0.95 | -0.66 |
| High Estimate | -0.22 | -0.17 | -0.61 | 0.16 |
| Year Ago EPS | -0.42 | -0.34 | -1.28 | -0.78 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 10 | 9 |
| Avg. Estimate | 83.4M | 102.36M | 452.85M | 748.01M |
| Low Estimate | 74.65M | 99.59M | 432.72M | 620.4M |
| High Estimate | 102.8M | 107.3M | 471.7M | 926.12M |
| Year Ago Sales | 715k | 31.11M | 164.07M | 452.85M |
| Sales Growth (year/est) | 11,563.73% | 229.08% | 176.01% | 65.18% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.41 | -0.35 | -0.3 | -0.27 |
| EPS Actual | -0.42 | -0.34 | -0.28 | -0.26 |
| Difference | -0.01 | 0.01 | 0.02 | 0.01 |
| Surprise % | -2.51% | 3.71% | 7.20% | 2.85% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.24 | -0.21 | -0.78 | -0.34 |
| 7 Days Ago | -0.24 | -0.21 | -0.79 | -0.32 |
| 30 Days Ago | -0.24 | -0.22 | -0.8 | -0.36 |
| 60 Days Ago | -0.26 | -0.23 | -0.86 | -0.29 |
| 90 Days Ago | -0.26 | -0.23 | -0.82 | -0.22 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | 5 | 1 |
| Up Last 30 Days | 2 | 2 | 5 | 2 |
| Down Last 7 Days | 1 | -- | 5 | 5 |
| Down Last 30 Days | 1 | 1 | 5 | 5 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IOVA | 43.84% | 37.19% | 38.83% | 56.88% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Maintains | Truist Securities: Buy to Buy | 3/3/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 3/3/2025 |
| Maintains | Chardan Capital: Buy to Buy | 3/3/2025 |
| Maintains | Baird: Outperform to Outperform | 2/28/2025 |
| Maintains | Piper Sandler: Neutral to Neutral | 2/28/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/28/2025 |
Related Tickers
IBRX ImmunityBio, Inc.
3.0500
+3.04%
TGTX TG Therapeutics, Inc.
39.82
+5.48%
VKTX Viking Therapeutics, Inc.
25.68
+7.40%
ALT Altimmune, Inc.
4.7800
+0.74%
AXSM Axsome Therapeutics, Inc.
109.75
-1.72%
SMMT Summit Therapeutics Inc.
20.46
+8.83%
NTLA Intellia Therapeutics, Inc.
7.30
+9.69%
MIST Milestone Pharmaceuticals Inc.
0.8031
+5.67%
BLUE bluebird bio, Inc.
5.03
-4.19%
SRPT Sarepta Therapeutics, Inc.
62.47
+0.90%